Class Action Complaint alleging securities fraud in Marko Busic v. Orphazyme A/S, of Denmark, described as “a biopharmaceutical company that develops therapies for the treatment of neurodegenerative orphan diseases”; Christophe Bourdon, Kim Stratton, Anders Vadsholt, Thomas Blaettler, Molly Painter, Georges Gemayel, Bo Jesper Hansen, Martin Bonde, Rémi Droller, Sten Verland, Martijn Kleijwegt, Anders Hedegaard, Catherine Moukheibir, and Carrolee Barlow at the U. S. District Court for the Northern District of Illinois.
- Home
- Documents
- Type
- Court Filings
- Civil
- Marko Busic v. Orphazyme A/S et al: Class Action Complaint
Civil Class Action Complaint Courts Denmark Documents Fraud Investment Listed Securities United States District Court for the Northern District of Illinois USAJuly 9, 2021
Marko Busic v. Orphazyme A/S et al: Class Action Complaint
36
July 09, 2021
Orphazyme A/S, Christophe Bourdon, Kim Stratton, Anders Vadsholt, Thomas Blaettler, Molly Painter, Georges Gemayel, Bo Jesper Hansen, Martin Bonde, Rémi Droller, Sten Verland, Martijn Kleijwegt, Anders Hedegaard, Catherine Moukheibir, Carrolee Barlow
Marko Busic
Topics
Denmark Fraud Investment Listed Securities USAKeywords
Anders Hedegaard Anders Vadsholt Bo Jesper Hansen Carrolee Barlow Catherine Moukheibir